BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 23935934)

  • 21. Abrogation of the interaction between osteopontin and alphavbeta3 integrin reduces tumor growth of human lung cancer cells in mice.
    Cui R; Takahashi F; Ohashi R; Gu T; Yoshioka M; Nishio K; Ohe Y; Tominaga S; Takagi Y; Sasaki S; Fukuchi Y; Takahashi K
    Lung Cancer; 2007 Sep; 57(3):302-10. PubMed ID: 17482311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of host-derived osteopontin creates a glioblastoma-promoting microenvironment.
    Szulzewsky F; Schwendinger N; Güneykaya D; Cimino PJ; Hambardzumyan D; Synowitz M; Holland EC; Kettenmann H
    Neuro Oncol; 2018 Feb; 20(3):355-366. PubMed ID: 29016864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stroma-derived but not tumor ADAMTS1 is a main driver of tumor growth and metastasis.
    Fernández-Rodríguez R; Rodríguez-Baena FJ; Martino-Echarri E; Peris-Torres C; Del Carmen Plaza-Calonge M; Rodríguez-Manzaneque JC
    Oncotarget; 2016 Jun; 7(23):34507-19. PubMed ID: 27120788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Silencing Osteopontin Expression Inhibits Proliferation, Invasion and Induce Altered Protein Expression in Melanoma Cells.
    Kiss T; Jámbor K; Koroknai V; Szász I; Bárdos H; Mokánszki A; Ádány R; Balázs M
    Pathol Oncol Res; 2021; 27():581395. PubMed ID: 34257527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The osteopontin-CD44 axis in hepatic cancer stem cells regulates IFN signaling and HCV replication.
    Shirasaki T; Honda M; Yamashita T; Nio K; Shimakami T; Shimizu R; Nakasyo S; Murai K; Shirasaki N; Okada H; Sakai Y; Sato T; Suzuki T; Yoshioka K; Kaneko S
    Sci Rep; 2018 Sep; 8(1):13143. PubMed ID: 30177680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of stromal JUNB does not affect tumor growth and angiogenesis.
    Braun J; Strittmatter K; Nübel T; Komljenovic D; Sator-Schmitt M; Bäuerle T; Angel P; Schorpp-Kistner M
    Int J Cancer; 2014 Mar; 134(6):1511-6. PubMed ID: 24027048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A host deficiency of discoidin domain receptor 2 (DDR2) inhibits both tumour angiogenesis and metastasis.
    Zhang S; Bu X; Zhao H; Yu J; Wang Y; Li D; Zhu C; Zhu T; Ren T; Liu X; Yao L; Su J
    J Pathol; 2014 Mar; 232(4):436-48. PubMed ID: 24293323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Macrophage migration inhibitory factor produced by the tumour stroma but not by tumour cells regulates angiogenesis in the B16-F10 melanoma model.
    Girard E; Strathdee C; Trueblood E; Quéva C
    Br J Cancer; 2012 Oct; 107(9):1498-505. PubMed ID: 22955855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Osteopontin-integrin interaction as a novel molecular target for antibody-mediated immunotherapy in adult T-cell leukemia.
    Maeda N; Ohashi T; Chagan-Yasutan H; Hattori T; Takahashi Y; Harigae H; Hasegawa H; Yamada Y; Fujii M; Maenaka K; Uede T
    Retrovirology; 2015 Nov; 12():99. PubMed ID: 26597716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravital Förster resonance energy transfer imaging reveals osteopontin-mediated polymorphonuclear leukocyte activation by tumor cell emboli.
    Kamioka Y; Takakura K; Sumiyama K; Matsuda M
    Cancer Sci; 2017 Feb; 108(2):226-235. PubMed ID: 27960041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting osteopontin suppresses glioblastoma stem-like cell character and tumorigenicity in vivo.
    Lamour V; Henry A; Kroonen J; Nokin MJ; von Marschall Z; Fisher LW; Chau TL; Chariot A; Sanson M; Delattre JY; Turtoi A; Peulen O; Rogister B; Castronovo V; Bellahcène A
    Int J Cancer; 2015 Sep; 137(5):1047-57. PubMed ID: 25620078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Osteopontin Deficiency Suppresses Intestinal Tumor Development in Apc-Deficient Min Mice.
    Ishigamori R; Komiya M; Takasu S; Mutoh M; Imai T; Takahashi M
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28505114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Notch1-MAPK Signaling Axis Regulates CD133
    Kumar D; Kumar S; Gorain M; Tomar D; Patil HS; Radharani NNV; Kumar TVS; Patil TV; Thulasiram HV; Kundu GC
    J Invest Dermatol; 2016 Dec; 136(12):2462-2474. PubMed ID: 27476721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells.
    Behera R; Kumar V; Lohite K; Karnik S; Kundu GC
    Carcinogenesis; 2010 Feb; 31(2):192-200. PubMed ID: 19926637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Osteopontin Promotes Hepatic Progenitor Cell Expansion and Tumorigenicity via Activation of β-Catenin in Mice.
    Liu Y; Cao L; Chen R; Zhou X; Fan X; Liang Y; Jia R; Wang H; Liu G; Guo Y; Zhao J
    Stem Cells; 2015 Dec; 33(12):3569-80. PubMed ID: 26033745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Osteopontin is an adhesive factor for myeloma cells and is found in increased levels in plasma from patients with multiple myeloma.
    Standal T; Hjorth-Hansen H; Rasmussen T; Dahl IM; Lenhoff S; Brenne AT; Seidel C; Baykov V; Waage A; Børset M; Sundan A; Hjertner O
    Haematologica; 2004 Feb; 89(2):174-82. PubMed ID: 15003892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Osteopontin induces growth of metastatic tumors in a preclinical model of non-small lung cancer.
    Shojaei F; Scott N; Kang X; Lappin PB; Fitzgerald AA; Karlicek S; Simmons BH; Wu A; Lee JH; Bergqvist S; Kraynov E
    J Exp Clin Cancer Res; 2012 Mar; 31(1):26. PubMed ID: 22444159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor-α9β1 integrin-mediated signaling induces breast cancer growth and lymphatic metastasis via the recruitment of cancer-associated fibroblasts.
    Ota D; Kanayama M; Matsui Y; Ito K; Maeda N; Kutomi G; Hirata K; Torigoe T; Sato N; Takaoka A; Chambers AF; Morimoto J; Uede T
    J Mol Med (Berl); 2014 Dec; 92(12):1271-81. PubMed ID: 25099519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spheroid-plug model as a tool to study tumor development, angiogenesis, and heterogeneity in vivo.
    Szade K; Zukowska M; Szade A; Collet G; Kloska D; Kieda C; Jozkowicz A; Dulak J
    Tumour Biol; 2016 Feb; 37(2):2481-96. PubMed ID: 26385771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osteopontin Signaling in Shaping Tumor Microenvironment Conducive to Malignant Progression.
    Butti R; Kumar TVS; Nimma R; Banerjee P; Kundu IG; Kundu GC
    Adv Exp Med Biol; 2021; 1329():419-441. PubMed ID: 34664250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.